SCOPE 2023: Beat AML Master Trial Successes
Len Rosenberg, head of clinical operations at Beat AML, discusses the outcome of his company's study, which was four years in the making.
In an interview at the 2023 SCOPE conference with ACT Editor-in-Chief, Lisa Henderson, Len Rosenberg, head of clinical operations at Beat AML, updates the public on the trial results (which he was a lead author of) and how the use of precision medicine guidelines played a role.
Recent Videos
Related Content
Moving Towards Decentralized Elements: Q&A with Scott Palmese, Worldwide Clinical Trials
December 6th 2024Article
Palmese, executive director, site relationships and DCT solutions, discusses the practice of incorporating decentralized elements in a study rather than planning a decentralized trial from the start.
